Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/07/25 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/07/25 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 1.56M 1.37M 1.27M 1.17M 2.21M 149M 2.25M 15.14M 5.92M 73.21M 5.85M 5.72M 253M | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -32.38M -28.44M -26.38M -24.25M -45.82M -3.1B -46.79M -314M -123M -1.52B -122M -119M -5.26B | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 31/03/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 30/11/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 06/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 30/11/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 19/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 19/06/24 | Free | Founder | 3,300 | 0.1115% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -93.90% | 1.56M | |
| +0.44% | +2.51% | +4.36% | +10.27% | 50.73B | |
| -1.57% | -2.80% | +383.82% | +582.81% | 39.73B | |
| -0.14% | +0.25% | +27.49% | -5.23% | 34.69B | |
| +1.76% | +2.12% | +21.44% | +58.27% | 33.21B | |
| -0.06% | -4.63% | +2.94% | +31.65% | 26.76B | |
| -1.93% | -3.38% | - | - | 16.8B | |
| -1.49% | -4.92% | +63.89% | +119.25% | 15.37B | |
| +0.78% | +0.20% | +14.69% | +17.08% | 13.78B | |
| -0.97% | -4.02% | +10.35% | -31.69% | 12.85B | |
| Average | -2.58% | -3.46% | +58.78% | +76.50% | 24.39B | |
| Weighted average by Cap. | +0.05% | -0.38% | +81.60% | +123.01% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.49M 1.31M 1.21M 1.12M 2.11M 142M 2.15M 14.47M 5.66M 69.99M 5.59M 5.47M 242M | 785K 690K 639K 588K 1.11M 75.06M 1.13M 7.62M 2.98M 36.87M 2.95M 2.88M 127M |
| Net income | -44.17M -38.8M -35.98M -33.09M -62.51M -4.22B -63.83M -429M -168M -2.07B -166M -162M -7.17B | -39.48M -34.68M -32.16M -29.57M -55.87M -3.77B -57.05M -383M -150M -1.85B -148M -145M -6.41B |
| Net Debt | -63.64M -55.9M -51.84M -47.67M -90.06M -6.08B -91.97M -618M -242M -2.99B -239M -234M -10.34B | -33.94M -29.81M -27.65M -25.42M -48.03M -3.25B -49.05M -330M -129M -1.59B -127M -125M -5.51B |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
